Claim 50% Off TipRanks Premium
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Hikal Limited ( (IN:HIKAL) ) just unveiled an update.
Hikal Limited has announced a significant corporate restructuring involving the transfer of equity shares due to the amalgamation of Shri Rameshwara Investment Private Limited and Shri Badrinath Investment Private Limited with Castilia Life Sciences Private Limited. This amalgamation, sanctioned by the Regional Director, Western Region, Mumbai, is expected to impact the company’s equity structure and potentially influence its market positioning.
More about Hikal Limited
Hikal Limited operates in the chemical and pharmaceutical industry, providing specialized solutions and products. The company focuses on manufacturing active pharmaceutical ingredients and intermediates, catering to various sectors including pharmaceuticals, animal health, and crop protection.
Average Trading Volume: 123,189
Technical Sentiment Signal: Hold
Current Market Cap: 31.19B INR
For detailed information about HIKAL stock, go to TipRanks’ Stock Analysis page.